SureTrader Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: BigKahuna, BooDog, noretreat, TOB, sox040713, TheHound
Search This Board:
Last Post: 6/24/2016 9:32:02 PM - Followers: 707 - Board type: Free - Posts Today: 109

Cellceutix Corporation (CTIX) i
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
About Cellceutix: 

Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Cellceutix is now preparing its FDA application for a Phase 2 ovarian cancer study. In the laboratory, Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is in a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of Oral Mucositis in patients with head and neck cancer. Brilacidin-OM, a defensin mimetic compound, has shown in an animal model to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol completed a Phase 2 trial. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria (Superbugs). Brilacidin is also being evaluated in a Phase 2 Proof-of-Concept trial as a novel treatment for Ulcerative Proctitis. Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available on the Cellceutix web site at www.cellceutix.com. 

Management:  http://cellceutix.com/team/

Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings (CIK:0001355250):  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:

EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275

 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CTIX News: Current Report Filing (8-k) 06/09/2016 04:10:03 PM
CTIX News: Quarterly Report (10-q) 05/09/2016 05:57:46 PM
CTIX News: Current Report Filing (8-k) 04/08/2016 10:04:54 AM
CTIX News: Current Report Filing (8-k) 03/31/2016 06:24:52 AM
CTIX News: Quarterly Report (10-q) 02/08/2016 04:03:50 PM
PostSubject
#152540  Sticky Note News from the judge ---> Possible sanctions for TheHound 06/22/16 09:39:27 AM
#151674  Sticky Note An ever quickening pace of achievement.... rmzport 06/15/16 09:36:03 PM
#148787  Sticky Note Cellceutix Phase 2 Trial of Prurisol for Mild sox040713 05/24/16 02:18:08 PM
#133344  Sticky Note We are looking forward ... to our fiscal noretreat 12/14/15 02:58:59 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#152882   Nope not in SanFran at the moment ,but winnail 06/24/16 09:32:02 PM
#152881   Are they lawyers? loanranger 06/24/16 09:22:11 PM
#152880   K-E-V-I-T-R-I-N or K-E-V-E-T-R-I-N? S.F.!! jav0033 06/24/16 09:20:46 PM
#152879   Here is what you do -go to your winnail 06/24/16 09:17:33 PM
#152878   Look forward to that update :) ericseb2003 06/24/16 09:12:33 PM
#152877   I don't believe the move for sanctions will KarinCA 06/24/16 08:45:27 PM
#152876   I'm still expecting a deal on Prurisol, but, KarinCA 06/24/16 08:31:48 PM
#152875   When are we going to hear anything about jav0033 06/24/16 08:30:57 PM
#152874   All it meant to me is someone with KarinCA 06/24/16 08:29:17 PM
#152873   cascott = do you have time and sales 1hb 06/24/16 08:28:58 PM
#152872   SOLID RESPONSE - Great post NotRichYet2 06/24/16 07:46:13 PM
#152871   It will be interesting to see the courts Ringrock 06/24/16 06:55:01 PM
#152870   I'm really looking forward to seeing the company frrol 06/24/16 06:29:46 PM
#152869   Russell rebalancing - today was last day - Amatuer17 06/24/16 06:23:23 PM
#152868   One is poster which is new but the Amatuer17 06/24/16 06:09:20 PM
#152867   Thanks Sox, have a good weekend. ericseb2003 06/24/16 06:08:28 PM
#152865   First time I've seen it...a little tough to Golfguru03 06/24/16 05:49:59 PM
#152864   i filed a complaint with the SEC for cascott 06/24/16 05:44:35 PM
#152863   One man's trash is another man's treasure. All sox040713 06/24/16 05:33:18 PM
#152862   Not very interesting on the whole. CTIX scottsmith 06/24/16 05:28:11 PM
#152861   Someone lost 50k shares of ammo at 931am cascott 06/24/16 05:22:11 PM
#152860   Eric, my expectation hasn't changed despite Brexit. I sox040713 06/24/16 05:19:23 PM
#152859   Activity of Potent and Selective Host Defense Peptide sox040713 06/24/16 05:11:09 PM
#152858   Sox, Karin and BK? Are you guys ericseb2003 06/24/16 05:02:21 PM
#152857   karinca, what do you think this means? cascott 06/24/16 04:49:07 PM
#152856   And closed just a tiny bit green. Yay! BigKahuna 06/24/16 04:28:44 PM
#152855   Thanks. Now available in 2 places: BigKahuna 06/24/16 04:23:03 PM
#152854   Scott man, Looks possible big up sp ahead 1hb 06/24/16 04:19:50 PM
#152853   The presentations are also available here: http://cellceutix.com/events/#sthash sox040713 06/24/16 04:18:43 PM
#152852   Looking forward to hearing your thoughts. First radcliff 06/24/16 03:45:59 PM
#152851   I don't recall it posted here before this. BigKahuna 06/24/16 03:38:15 PM
#152850   My apologies. I see this is a radcliff 06/24/16 03:35:45 PM
#152849   Posted on Facebook today. radcliff 06/24/16 03:28:52 PM
#152848   Was slightly red, but now slightly green again. BigKahuna 06/24/16 02:56:01 PM
#152847   And why robust Phase 3's are so necessary. frrol 06/24/16 02:33:12 PM
#152846   Thank You Karen for posting the charts. TheBunny 06/24/16 01:52:21 PM
#152845   Two blocks traded today, one for 35K and luxe 06/24/16 01:51:57 PM
#152844   Ok they took the block, 10K more shares luxe 06/24/16 01:47:54 PM
#152843   Greed is good greed works! Come on Gordo luxe 06/24/16 01:45:15 PM
#152842   Are we green still? What's happening? scottsmith 06/24/16 01:43:11 PM
#152841   Isn't ironic that the volume is 161,300 and luxe 06/24/16 01:43:03 PM
#152840   It's interesting that the largest block sale on KarinCA 06/24/16 01:31:01 PM
#152838   Bunny… Different charts show differing things… For example: KarinCA 06/24/16 01:09:19 PM
#152837   Checking an hour later and it's still the BigKahuna 06/24/16 01:08:48 PM
#152836   CTIX NOW UP YTD 5.26%. BIB NOW DOWN 58nout 06/24/16 01:01:22 PM
#152835   CTIX now the tiniest bit green in a BigKahuna 06/24/16 12:43:36 PM
#152834   It's funny that the very first source linked BigKahuna 06/24/16 12:41:22 PM
#152833   Hopefully you are correct. The ctix shareholder scottsmith 06/24/16 12:40:42 PM
#152832   Just the strength in today's blood bath should septmike09 06/24/16 12:39:23 PM
#152831   Nope, can't top it. This is from Bunny's sox040713 06/24/16 12:32:30 PM
PostSubject